Your browser doesn't support javascript.
loading
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Patients with Type 2 Diabetes (TROPHIES): Patient disposition, clinical characteristics and treatment persistence at 12 months.
Guerci, Bruno; Giorgino, Francesco; Sapin, Hélène; Boye, Kristina; Lebrec, Jérémie; Federici, Marco Orsini; Heitmann, Elke; Dib, Anne; Füchtenbusch, Martin; García-Pérez, Luis-Emilio.
Afiliación
  • Guerci B; Department of Endocrinology, Diabetology and Nutrition, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
  • Giorgino F; Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.
  • Sapin H; Statistics and Real World Analytics, Lilly France SAS, Neuilly-sur-Seine, France.
  • Boye K; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Lebrec J; Real World Access and Analytics, HaaPACS GmbH, Schriesheim, Germany.
  • Federici MO; Medical Affairs, Eli Lilly Italia SpA, Sesto Fiorentino, Italy.
  • Heitmann E; Medical Affairs, Lilly Deutschland GmbH, Bad Homburg, Germany.
  • Dib A; Medical Affairs, Lilly France SAS, Neuilly-sur-Seine, France.
  • Füchtenbusch M; Diabetes Research Institute, Munich, Germany.
  • García-Pérez LE; Diabetes Global Medical Affairs, Lilly, S.A., Alcobendas, Spain.
Diabetes Obes Metab ; 24(12): 2373-2382, 2022 12.
Article en En | MEDLINE | ID: mdl-35876235

Texto completo: 1 Colección: 01-internacional Asunto principal: Diabetes Mellitus Tipo 2 / Liraglutida Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Asunto principal: Diabetes Mellitus Tipo 2 / Liraglutida Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2022 Tipo del documento: Article País de afiliación: Francia